BioMed Ventures is the corporate venture arm of BioMed Realty. It invests in companies in the life science industry.
BioMed Ventures has invested in Compass Therapeutics, AEGEA Medical, Amplyx Pharmaceuticals, Effector Therapeutics, NeuroVia, Sensely, Syndax Pharmaceuticals, Genalyte and AnaptysBio.
They have exits in NanoString Technologies, AnaptysBio, Zosano Pharma, Histogenics, TRACON Pharmaceuticals, Syndax Pharmaceuticals, Edge Therapeutics and Auspex Pharmaceuticals.
They have exits in NanoString Technologies, AnaptysBio, Zosano Pharma, Histogenics, TRACON Pharmaceuticals, Syndax Pharmaceuticals, Edge TherapeuticsEdge Therapeutics and Auspex Pharmaceuticals.
BioMed Ventures has invested in Compass TherapeuticsCompass Therapeutics, AEGEA Medical, Amplyx Pharmaceuticals, Effector Therapeutics, NeuroVia, Sensely, Syndax Pharmaceuticals, Genalyte and AnaptysBio.